Australian Entertainment Stock News

ASX:NWL
ASX:NWLCapital Markets

Netwealth Group H1 2026 Margin Compression Challenges Bullish High P/E Narrative

Netwealth Group (ASX:NWL) has just reported its H1 2026 results, with H2 2025 revenue at A$169.0 million and basic EPS of A$0.24, alongside trailing 12 month revenue of A$362.8 million and EPS of A$0.23. The company has seen revenue move from A$131.9 million and EPS of A$0.18 in H2 2024 to A$155.4 million and EPS of A$0.24 in H1 2025, then to A$169.0 million and EPS of A$0.24 in H2 2025. These developments set the stage for investors to weigh the latest numbers against a backdrop of softer...
ASX:SRV
ASX:SRVReal Estate

Servcorp H1 2026 Margins Dip To 15.7% Testing Bullish Scale Narratives

Servcorp (ASX:SRV) has reported its H1 2026 results with total revenue of A$182.1 million and basic EPS of A$0.19, setting the tone for how the rest of the year might shape up for shareholders focused on the income line. The company has seen revenue move from A$158.7 million in H2 2024 to A$167.7 million in H1 2025 and then to A$182.1 million in H2 2025, while basic EPS over those same halves came in at A$0.20, A$0.35 and A$0.19 respectively. This gives investors a clear view of how the top...
ASX:ACL
ASX:ACLHealthcare

A Look At Australian Clinical Labs (ASX:ACL) Valuation After Softer Half Year Earnings And Interim Dividend

Australian Clinical Labs (ASX:ACL) is in focus after reporting half year 2025 results that show lower net income while sales remained close to prior levels, and the company also declared a fully franked interim dividend. See our latest analysis for Australian Clinical Labs. The latest half year result and interim dividend have arrived against a weaker backdrop for shareholders, with the share price at A$2.15 after a 30 day share price return decline of 15.35% and a 1 year total shareholder...
ASX:BOT
ASX:BOTPharmaceuticals

A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings

Botanix Pharmaceuticals (ASX:BOT) has drawn fresh attention after filing multiple follow on equity offerings totaling A$45 million. The company is issuing new ordinary shares at A$0.06 with attached options that could reshape its capital structure. See our latest analysis for Botanix Pharmaceuticals. That equity raising lands after a sharp reset in sentiment, with a 1 day share price return showing a 41.33% decline at the latest A$0.066 close and a 1 year total shareholder return of 86.80%...
ASX:IMM
ASX:IMMBiotechs

3 ASX Penny Stocks With Market Caps Under A$600M

Australian shares are on the rise, bolstered by a strong February reporting season and modest gains on Wall Street, contributing to an optimistic outlook for investors. For those willing to explore beyond the well-known blue-chip stocks, penny stocks—often representing smaller or newer companies—offer intriguing possibilities. While the term may seem outdated, these stocks continue to present opportunities for growth at lower price points when supported by solid financials and fundamentals.
ASX:ZIP
ASX:ZIPConsumer Finance

Zip Co Trust Rebrand And Campaign Tested Against Valuation And Momentum

Zip Co (ASX:ZIP) has launched a new brand platform called "In You We Trust". The company has rolled out a national "You Trust Me?" campaign to support the new positioning. Alongside the branding shift, Zip Co is introducing product updates and new app features focused on trust and flexibility. Zip Co operates in digital financial services, where competition from both traditional banks and newer fintechs has been intense. By centering its new platform on trust and customer control, ASX:ZIP...
ASX:OML
ASX:OMLMedia

3 ASX Dividend Stocks With Up To 6% Yield

In the last week, the Australian market has remained flat, but over the past 12 months, it has seen a modest rise of 3.6%, with earnings forecasted to grow by 12% annually. In this environment, selecting dividend stocks with solid yields can be an effective strategy for investors seeking steady income and potential growth in their portfolios.
ASX:BBN
ASX:BBNSpecialty Retail

ASX Penny Stocks Spotlight: Baby Bunting Group And 2 More Hidden Opportunities

As Australian shares gear up for a modest open amid the bustling February reporting season, investors are keeping a close watch on the Reserve Bank of Australia's latest policy meeting minutes. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies that can offer unique investment opportunities. By focusing on those with solid financial foundations and growth potential, investors might uncover hidden gems in the market.
ASX:WHI
ASX:WHICapital Markets

Whitefield Income H1 2026 Very Large Earnings Jump Tests Bullish Narratives On Profitability

Whitefield Income (ASX:WHI) has released its H1 2026 scorecard, with investors watching how the latest A$16.97 million in trailing twelve month revenue and A$13.39 million in net income feed through to EPS of A$0.159634 on a A$1.425 share price. The company has reported revenue of A$2.04 million and EPS of A$0.058984 in H1 2025, followed by A$8.22 million in revenue and EPS of A$0.04039 in H2 2025, contributing to a reported earnings jump of roughly 8x over the past year and a net profit...
ASX:BWP
ASX:BWPRetail REITs

Undervalued Small Caps With Insider Activity In Global Markets February 2026

In February 2026, global markets are navigating a landscape marked by concerns over AI disruption, robust U.S. job gains that have tempered rate cut expectations, and mixed performances across major indices. While the S&P 600 for small-cap stocks has faced its share of volatility amid these broader market shifts, opportunities may still exist for discerning investors who focus on companies with solid fundamentals and active insider participation.
ASX:CGS
ASX:CGSHealthcare Services

Undervalued Asian Small Caps With Insider Action February 2026

As Asian markets navigate a complex landscape marked by modest gains in Chinese stocks and economic shifts in Japan, small-cap companies are drawing attention amid broader market fluctuations. With the backdrop of these regional dynamics, identifying promising small-cap stocks often involves examining insider actions and valuations that align with current economic conditions.